Dakwah humanis dengan pendekatan sosiologis-antropologis od Bukhari, M.AG

Polni tekst

Baseline retinal testing is no longer recommended for hydroxychloroquine users in the United Kingdom od Yusuf, I, Bukhari, M, Galloway, J, Lotery, AJ

Synthesis and anti-bacterial activities of some novel pyrazolobenzothiazine-based chalcones and their pyrimidine derivatives od Bukhari, M, Siddiqui, H, Ahmad, M, Hussain, T, Moloney, M

Synthesis and anti-bacterial activities of some novel pyrazolobenzothiazine-based chalcones and their pyrimidine derivatives od Bukhari, M, Siddiqui, H, Ahmad, M, Hussain, T, Moloney, M

Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom od Taylor, PC, Woods, M, Rycroft, C, Patel, P, Blanthorn-Hazell, S, Kent, T, Bukhari, M

Enhancing current guidance for psoriatic arthritis and its comorbidities: recommendations from an expert consensus panel od Coates, LC, Bukhari, M, Chan, A, Choy, E, Galloway, J, Gullick, N, Kent, A, Savage, L, Siebert, S, Tillett, W, Wood, N, Conaghan, PG

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy (vol 49, pg 1197, 2010) od Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis. od Bukhari, M, Abernethy, R, Deighton, C, Ding, T, Hyrich, K, Lunt, M, Luqmani, R, Kiely, P, Bosworth, A, Ledingham, J, Ostör, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. od Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy. od Deighton, C, Hyrich, K, Ding, T, Ledingham, J, Lunt, M, Luqmani, R, Kiely, P, Bukhari, M, Abernethy, R, Ostor, A, Bosworth, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies. od Ding, T, Ledingham, J, Luqmani, R, Westlake, S, Hyrich, K, Lunt, M, Kiely, P, Bukhari, M, Abernethy, R, Bosworth, A, Ostor, A, Gadsby, K, McKenna, F, Finney, D, Dixey, J, Deighton, C

Relapse after cessation of weekly tocilizumab for giant cell arteritis: a multicentre service evaluation in England od Quick, V, Abusalameh, M, Ahmed, S, Alkoky, H, Bukhari, M, Carter, S, Coath, FL, Davidson, B, Doddamani, P, Dubey, S, Ducker, G, Griffiths, B, Gullick, N, Heaney, J, Holloway, A, Htut, EEP, Hughes, M, Irvine, H, Kinder, A, Kurshid, A, Lim, J, Ludwig, DR, Malik, M, Mercer, L, Mulhearn, B, Nair, JR, Patel, R, Robson, J, Saha, P, Tansley, S, TOC STOP 2022 Investigators, Mackie, SL